Since 2009, RJS’s scientists have been at work developing novel cancer therapeutics and therapies for patients with severe illnesses.  Our scientists have characterized key cellular processes that have led to the development of innovative, first-in-class therapeutic platforms.  Our deep commitment to building a corporate culture that embraces science and creative innovation allows us to lead rather than simply walk in the footsteps of other pharmaceutical companies.  This energetic spirit continues to shape who we are today.